Overview

Insulin Cardioplegia for Poor Left Ventricular Function

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to develop a means to improve the recovery of cardiac metabolism and ventricular function following coronary artery bypass surgery (CABG) in patients with poor preoperative ventricular function (e.g. ejection fraction <40%).
Phase:
N/A
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Insulin
Insulin, Globin Zinc